www.argostherapeutics.com

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 54 Argos Therapeutics 51 Monoclonal Antibody 49 Combination Therapy 49 Presents Positive 49 InNexus Biotechnology Inc. 49 immunotherapeutics 48 Hybridon 48 Pivotal Study 48 Receives Orphan Drug Designation 48 Nasdaq ASTM 48 LAVAL QC 48 Initiates Phase II 48 Antifungal 47 Small Molecule 47 Preclinical Data 47 Idera Pharmaceuticals 47 Clinical Trial Results 47 Inc. NASDAQ MRNA 47 Full Prescribing Information 47 Epitomics 47 BioMS Medical Corp. 47 Recombinant Human 46 Inc Therapeutic Competitors 46 humanized antibody 46 Clinical Trial 46 Develop Novel 46 Cancer Vaccines 46 Drug Candidate 46 Alzhemed TM 46 GlaxoSmithKline plc GSK 46 Targeted Therapy 46 THERAPEUTICS 46 Neurodegenerative Diseases 46 Protease 45 www.patheon.com 45 Adherex Technologies Inc. 45 Shows Promise 45 TLR9 agonist 45 Initiates Phase 45 Commences Phase 45 Generex Biotechnology Corp. 45 Chemokine Therapeutics 45 Anti Inflammatory 45 refractory chronic lymphocytic 45 LIFE SCIENCES 45 SAR# [004] 45 Exploit collaboration 45 Phase III Clinical Trial 45 Commercialize 45 ImmunoCellular Therapeutics 44 BIOTECHNOLOGY 44 Sangamo BioSciences 44 theranostic 44 CureDM 44 Lifesciences 44 Atopic Dermatitis 44 FDA Clears 44 peptide synthesis 44 Acquires Exclusive 44 Aegera 44 Phase Ib clinical 44 Nasdaq ENZN 44 Pathogenesis 44 targeting CD# 44 Antisense 44 Significantly Improves 44 Tranzyme Pharma 44 Announces FDA Clearance 44 Haemacure Corporation 44 Coley Pharmaceutical Group 44 Cancer Cells 44 RNA Interference 44 antiviral therapeutics 44 Elixir Pharmaceuticals 44 anti CD# monoclonal 44 Hepatocellular Carcinoma 44 drug conjugate 44 Factor VIIa 44 Completes Enrollment 44 Cenix 44 Initiate Phase 44 Paladin Labs 44 JAK1 44 www.gsk.com 44 RNAi Therapeutics 44 www.labopharm.com 44 http:/cts.businesswire.com/ct/CT?id=smartlink&urlAND EVEN 44 Scancell 44 Allon Therapeutics Inc. 44 Product Pipeline 44 Receives Patent 44 Pulmonary Arterial Hypertension 44 Phase Ib II 44 orally bioavailable 44 Preclinical Studies 44 Single Dose 43 BIOTECH 43 QIAGEN NV 43 Helix BioMedix Inc. 43 Significantly Reduces 43 Inc. Nasdaq IMGN

Back to home page